Abattis Bioceuticals
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
355 Burrard St Ste 1000, Vancouver, Brit...Phone Number
(808) 650-3007Website
www.abattis.comRevenue
<$5 MillionStock Symbol
ATTIndustry
About Abattis Bioceuticals
Abattis Bioceuticals Org Chart
Is Abattis Bioceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Abattis Bioceuticals recently announced quarterly report
Check out if Abattis Bioceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Abattis Bioceuticals
Funding: Get notified immidiatlly once Abattis Bioceuticals has new funding data
Abattis Bioceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Abattis Bioceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Abattis Bioceuticals launches new products
Click to see if Abattis Bioceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Abattis Bioceuticals as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Abattis Bioceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Abattis Bioceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Abattis Bioceuticals.
Abattis Bioceuticals Tech Stack
A closer look at the technologies used by Abattis Bioceuticals
Abattis Bioceuticals News & Media
Abattis Provides Update on Trading Halt and Corporate Developments
VANCOUVER, British Columbia, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) announces the following updates on recent developments related to Abattis since the trading of the Company’s common shares on the Canadian Stock Exchange (the “CSE”) was halted on February 4, 2019 (the “Halt”).Abattis Completes Year End Audit and Provides Corporate Update
VANCOUVER, British Columbia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) announces the filing of its annual financial statements for the year ended September 30, 2018 and is pleased to provide the following comprehensive update on recent developments related to Abattis since the trading of the Company’s common shares (each, a “Share”) was halted on the Canadian Securities Exchange (“CSE”) on February 4, 2019.Abattis Announces Successful Closing of Pro Natura Acquisition
VANCOUVER, British Columbia, May 21, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its news release dated April 2nd, 2019, the Company’s wholly-owned subsidiary, 1185277 B.C. Ltd. (the “Acquisition Subsidiary”) has successfully closed the acquisition (the “Acquisition”) of Pro Natura BV (“Pro Natura”).Abattis Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates
VANCOUVER, British Columbia, April 2, 2019 /PRNewswire/ -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT) (OTC: ATTBF) is pleased to announce that its wholly-owned subsidiary, 1185277 B.C. Ltd. (the "Acquisition Subsidiary"), has entered into a share purchase agreement ...
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Abattis Bioceuticals
Founded in 1997 and headquartered in Vancouver, British Columbia, Abattis Bioceuticals is a life sciences and biotechnology company that aggregates, integrates, and invests in cannabis technologies and biotechnology services for the legal cannabis industry in Canada.... Read More